pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3937 |
Genomic Coordinates | chrX: 39661216 - 39661321 |
Description | Homo sapiens miR-3937 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3937 | |||||||||||||||||||||
Sequence | 61| ACAGGCGGCUGUAGCAAUGGGGG |83 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FAM83H | ||||||||||||||||||||
Synonyms | AI3, AI3A | ||||||||||||||||||||
Description | family with sequence similarity 83 member H | ||||||||||||||||||||
Transcript | NM_198488 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FAM83H | |||||||||||||||||||||
3'UTR of FAM83H (miRNA target sites are highlighted) |
>FAM83H|NM_198488|3'UTR 1 GTCTTCTGGCCTGGCAACCCAGGCCAGGGTGCCCGCATCGCTGCCCCGGTCATCCAGAAGCCCCGCGGAACAGAGAGCCC 81 TGCTCATGTGCTTGAGCAGCGGCTGTCAGGCCACGGCCGCTTGGGGCTTGGCTGAGTGCGCCAGACCTCGGCTCCACTGG 161 AGGCTCACCTGGCAGCTGCCGTCTCTGCCCCCTGGCCTCCCCAACGCTGGGGCTGCACCCCTCGCCACCAGTGCCTTTCT 241 CCCCTCAGCACCTTCATCTCTGCACCGTCAGCCTTGCGTGGCGCAGCGTCTGGCTCCGCCATCTCTTTGTGCCTCAGTCC 321 CCCCCGCCCCCTTTATTTTTTTGAGACCTAGGGCTGGAGTGCAGTTGAGCGGTCTGGGCTCACTGCAACCTCTGCCTCCC 401 GGGTTCCAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGATGTATGCTACCACGCCCAGGTAGTTTTTG 481 TATTTTTAGTAGAGACAGGGTTTCACTATGTTGGCCAGGCTGGTCTCCAACTCCTGGCCTCAAATGATCAGCCCGCTTCA 561 GCCTCCCAAAGTGGGGGGATTACAGGCGTGAGCCTTGCACCCCGCTAAGTCCCCTATCCTCTTGCAAGGGTCTCGCCTCT 641 GTGCCTCAATTCCTCATTCTCTGGGCCCTTCTCCTCCTCAGGGCCTCCTGTTCTCAGGGCCTCCCCCCTCCCCGCTCCCT 721 CCCTCTCTCAAGGTCTCCTCCTTCCCTCCCCCCCCCGTCTCCCCCCTCCCCCGCCTGGGCTTCACTTCCTTTCCTACTTG 801 GATTCTCCTGCTCGCTGCCTCCCAGCATCTTTTTTGGAGGCCCGTCTCTTGCTGTGGGGAAGACTGGGCTGGCTGCGGGC 881 AGTTTGCAAGGGGTGGGTGGGGCGGGGGGGGGAGCTGGACCAGAAGATGCCCCTTGGAGTGGCAAGGAAGCTGGACAGGG 961 CAGGCCTCTGGGGACGGGACACAGGGAAGCCCGAAGGGGCGCCTTGGCCAGGTCTGCCATCTCCTCCAGCGAGGCTCTGG 1041 CCAGCACTGGGTGAGAGTGGGGAGGGGGCACTGGCCTTTGCAGCACAGTAAAACATGGTCCAGACAACCTGTGGCCCCGG 1121 CCTCATGAGCACCCCCTGCACAGGCCCGGCCCAAGCCAGGCGCTAGAAGGGCTGGTTGTGGAGTGCTTATCCTTGACAGG 1201 TATGGGGCCAGGTGAGGGCAGGGGACAAGGTGCAGCTGAGGCCGAGCCCAACTAGGTCCTGGGCACCCCTGCAGGTGGGA 1281 GTGGTCCTTGTCCTCCTGGTATCCAGCAGACACCCCCCTCTCCCCACCAGCCCCATTCTCAGGTCCTTTCCTCTTTGTCA 1361 CCAACACCAAGAATCTGTCCAGGGTTCTTGGCTTATCTTTTATCTCTTTTCACTCCTAGAGAGGAATTGCAATTGACTCA 1441 GAATGACACATTTTGGCACCACGTGTGTAGAAAGCCCCCACTGTTAGATGATAGCCTCGTGAAATTCATGTTTCTGTATT 1521 CTCCTATTTCTTTTCAAAAACTAATTTTTTTTTTAGTGTAATAAATCCTAAGAGGGAACTGATTTAAGAAACAAGGCCGC 1601 CAAACAAAGGCAGCAGTTCCGACTCCAGCAGCTGGGAAAGGAAGGAAAGTGACCCCACTTTCACTCCTGCACAGCCCACT 1681 GGTTACCAAAACCACCGTGCAAGTCGGGATGACAGCAGGGACTTCTGGCCAGGTGGGAAAGGTGCCTGGAAGCGGGATGC 1761 GCCTGTGCGTCTCTTGGCCATGATGTTCTTGTGGGCATGTTATTCTTGGTGCTGCCTGGGGTGTTGCTGAGCGGACAGGC 1841 TCTCCAGCTGGAGTCCATGGAGAGGCCAGAGGCTGGCGGCCCTGCCTGGGCCTTCGGAGCCTCCTGCCTGCACCCTCCAC 1921 CTCTTCTAAACCATGATGTGGCACATTTTGGTGTTAATAAAACACAACACACAAAGTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177604. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_6
PAR-CLIP data was present in ERX177616. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_6
PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000388913.3 | 3UTR | CCCGUCUCCCCCCUCCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000388913.3 | 3UTR | CCCCGUCUCCCCCCUCCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000388913.3 | 3UTR | CCCGUCUCCCCCCUCCCCCGCCUGGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
40 hsa-miR-3937 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT332487 | CD81 | CD81 molecule | 2 | 2 | ||||||||
MIRT441327 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 4 | ||||||||
MIRT454032 | EIF3CL | eukaryotic translation initiation factor 3 subunit C like | 2 | 2 | ||||||||
MIRT458086 | EIF3C | eukaryotic translation initiation factor 3 subunit C | 2 | 2 | ||||||||
MIRT460785 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT463150 | ZNF385A | zinc finger protein 385A | 2 | 4 | ||||||||
MIRT467162 | SREBF2 | sterol regulatory element binding transcription factor 2 | 2 | 2 | ||||||||
MIRT469618 | RAI1 | retinoic acid induced 1 | 2 | 4 | ||||||||
MIRT472258 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT487587 | FAM83H | family with sequence similarity 83 member H | 2 | 4 | ||||||||
MIRT489302 | B4GALNT4 | beta-1,4-N-acetyl-galactosaminyltransferase 4 | 2 | 4 | ||||||||
MIRT489741 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT490038 | PCSK4 | proprotein convertase subtilisin/kexin type 4 | 2 | 2 | ||||||||
MIRT490767 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491750 | SEMA3F | semaphorin 3F | 2 | 2 | ||||||||
MIRT492690 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT504843 | RRP36 | ribosomal RNA processing 36 | 2 | 4 | ||||||||
MIRT510116 | IRAK3 | interleukin 1 receptor associated kinase 3 | 2 | 8 | ||||||||
MIRT525313 | FANCA | Fanconi anemia complementation group A | 2 | 4 | ||||||||
MIRT569801 | IGDCC3 | immunoglobulin superfamily DCC subclass member 3 | 2 | 2 | ||||||||
MIRT570224 | SLC27A1 | solute carrier family 27 member 1 | 2 | 2 | ||||||||
MIRT629378 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | 2 | 2 | ||||||||
MIRT633104 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT645036 | ATAD3C | ATPase family, AAA domain containing 3C | 2 | 2 | ||||||||
MIRT660973 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT671225 | CLSTN1 | calsyntenin 1 | 2 | 2 | ||||||||
MIRT672046 | SMTNL2 | smoothelin like 2 | 2 | 2 | ||||||||
MIRT677314 | CPSF2 | cleavage and polyadenylation specific factor 2 | 2 | 2 | ||||||||
MIRT678290 | PTRH2 | peptidyl-tRNA hydrolase 2 | 2 | 2 | ||||||||
MIRT693477 | ZNF707 | zinc finger protein 707 | 2 | 2 | ||||||||
MIRT693576 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT696832 | PLLP | plasmolipin | 2 | 2 | ||||||||
MIRT700149 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT703760 | FAM118A | family with sequence similarity 118 member A | 2 | 2 | ||||||||
MIRT705798 | ALDH6A1 | aldehyde dehydrogenase 6 family member A1 | 2 | 2 | ||||||||
MIRT709105 | SEPT4 | septin 4 | 2 | 2 | ||||||||
MIRT710235 | ARMCX6 | armadillo repeat containing, X-linked 6 | 2 | 2 | ||||||||
MIRT711422 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT712529 | CYTH2 | cytohesin 2 | 2 | 2 | ||||||||
MIRT714081 | ZNF532 | zinc finger protein 532 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|